Raqobat qömitasi dori importidagi yirik öyinçilarni ogohlantirdi.
Five companies account for 47 percent of drug imports into Uzbekistan. Concentration is also increasing in retail sales. Complaints have emerged that some importers and distributors force the purchase of other preparations when selling high-demand drugs. The competition committee has warned these major players. Oligopolists will face fines if anti-competitive actions are confirmed.
Özbekistonga dori-darmon importining 47 foizi 5 ta kompaniya hissasiga töğri kelyapti. Çakana savdoda ham konsentratsiya oşmoqda. Şunday şaroitda ayrim importyorlar va distribyutorlar talabgir dorilarni sotişda boşqa preparatlarni ham majburiy tarzda qöşib sotayotgani haqida şikoyatlar bor. Agar tekşiruvlarda raqobatga zid harakatlar tasdiqlansa, oligopolistlar jarimaga tortiladi..